4
Changes in Ownership
Spyre Therapeutics, Inc. Filed Acc 0000950170-24-010901
Options or other derivatives
- Chief Financial Officer acquired 70,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Burrows Scott L Chief Financial Officer | 2024-02-01 | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…